GlassScriptPhysician profile
Elizabeth A Baker
NPI 1225090210
$3,369.44
in general payments reported to CMS, 2019-2025
31 companies · $222 in 2025
The $222 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,794 · 2020: $430 · 2021: $144 · 2022: $252 · 2023: $266 · 2024: $261 · 2025: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $749.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $749.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $789.35 | 2019-2024 | Mild Device Kit |
| Abbott Laboratories | $690.27 | 2019-2023 | Proclaim |
| Nevro Corp. | $300.87 | 2019 | |
| Collegium Pharmaceutical, INC. | $252.77 | 2019-2025 | Belbuca, Xtampza |
| Spr Therapeutics, INC | $187.35 | 2024-2025 | Sprint Pns System |
| Stratus Medical, LLC | $179.14 | 2020-2023 | Nimbus |
| Centinel Spine, LLC | $130.44 | 2019 | |
| Allergan, INC. | $103.55 | 2019-2022 | |
| Arbor Pharmaceuticals, INC. | $79.90 | 2019-2022 | |
| Bioventus LLC | $65.46 | 2021-2025 | Xcell |
| Azurity Pharmaceuticals, INC. | $64.76 | 2023-2025 | Horizant, Horizant |
| Abbvie INC. | $62.15 | 2022-2024 | |
| Biodelivery Sciences International, INC. | $54.43 | 2020-2021 | |
| Electronic Waveform Lab, INC. | $47.36 | 2023 | |
| Boston Scientific Corporation | $46.90 | 2019-2020 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $31.67 | 2022 | |
| Ferring Pharmaceuticals INC. | $26.35 | 2019-2021 | |
| Depuy Synthes Sales INC. | $26.32 | 2019 | |
| Pfizer INC. | $25.75 | 2019 | |
| Scilex Pharmaceuticals INC. | $25.54 | 2019 | |
| Vertiflex, INC. | $22.49 | 2019 | |
| Avanos Medical | $20.77 | 2022 | |
| Averitas Pharma INC. | $18.46 | 2025 | Qutenza |
| Fidia Pharma USA INC. | $16.32 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.14 | 2024 | Relistor |
| Ibsa Pharma INC. | $15.94 | 2024 | Licart, Tirosint |
| Amgen INC. | $15.17 | 2024 | Prolia, Evenity |
| Shionogi INC | $14.38 | 2019 | |
| Stimwave Technologies Incorporated | $13.79 | 2022 | |
| Trevena, INC. | $13.55 | 2021 | |
| Orthogenrx INC. | $12.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.